Skip directly to content
Updates

House Report Recommends Against "Gutting" Food Assistance

Anti-hunger advocates were relieved to hear that our message that the Supplemental Nutrition Assistance Program (SNAP) is working is getting through to Congress. This week, the House released a report on a two-year, top-to-bottom review of SNAP and found that the program is effective and necessary.

In an statement published at Politico, House Agriculture Committee Chair Mike Conway (R-Texas) said "You will find nothing in this report that suggests gutting SNAP or getting rid of a program that does so much to serve so many."

This represents somewhat of a reversal on previous statements,

Tags: 

FairShareSlate.png

Fair Share endorsed 48 candidates across the country in U.S. Senate and U.S. House races, 32 of which won election.

Fair Share looks forward to working with these members Congress who share our vision of a future that gives all Americans -- not just the powerful or the lucky or the super-talented few -- the opportunity to lead fulfilling lives in a changing economy.

Study: Offshore Corporate Cash Stockpile Up to $2.5 Trillion

73% of Fortune 500 Companies used tax havens in 2015, dodging $717.8 billion in federal taxes in the process.

A new report, "Offshore Shell Games," by the U.S. PIRG Education Fund, Citizens for Tax Justice and the Institute on Taxation and Economic Policy details how these companies hoard cash offshore. Collectively, multinationals reported booking $2.5 trillion offshore, with just 30 companies accounting for 66 percent of this total.

The cost to the tax payer is huge, with nearly $718 billion in dodged taxes.

There is a real cost to our communities when we allow a set of companies to play

We need to look into EpiPen

The makers of EpiPen testified in front of Congress -- and it was an epic fail.

They failed to justify their 500% price increase, their 600% increase in executive pay, or their tax-dodging move of corporate offices to the Netherlands.1

Join our campaign to tell the FTC to investigate Mylan for price-gouging and anti-competitive behavior.

Since acquiring the product in 2007, Mylan has raised the price of an EpiPen two-pack from a little over $90 to more than $600.2

Imagine you’re the parent of a child who suffers severe allergic reactions. You depend on the EpiPen to keep your child safe.

ACTION: Anonymous and deadly

There are many reasons why we should ban the practice of anonymous shell companies -- companies formed with no way of knowing who is in charge.

But here's one of the most compelling: They're being used to shield illegal opioid dealers. Most businesses have nothing to hide, but if you do have something to hide, it's easy: You just set up an anonymous shell company -- which in America, requires less personal information than it takes to get a library card.

Since they're anonymous, shell companies are a favorite tool to hide all sorts of unsavory behaviors, from terrorism and drug cartels to

Tags: 

Pages